📣 VC round data is live. Check it out!

Eukedos Valuation Multiples

Discover revenue and EBITDA valuation multiples for Eukedos and similar public comparables like MedNation, Concord Medical Services, Gesundheitswelt Chiemgau, Speed Medical SAE and more.

Eukedos Overview

About Eukedos

Eukedos SpA along with its holdings provides healthcare and medical products. The company manages retirement homes for elderly and adults disabled.


Founded

2006

HQ

Italy

Employees

1.0K

Website

eukedos.it

Financials (FY)

Revenue: $62M
EBITDA: $13M

EV

$167M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Eukedos Financials

Eukedos reported last fiscal year revenue of $62M and EBITDA of $13M.

In the same fiscal year, Eukedos generated $59M in gross profit, $13M in EBITDA, and had net loss of ($871K).


Eukedos P&L

In the most recent fiscal year, Eukedos reported revenue of $62M and EBITDA of $13M.

Eukedos is unprofitable as of last fiscal year, with gross margin of 95%, EBITDA margin of 21%, and net margin of (1%).

See analyst estimates for Eukedos
Last FY202320242025202620272028
Revenue$62M$58M$60M$62M
Gross Profit$59M$54M$57M$59M
Gross Margin95%94%95%95%
EBITDA$13M$14M$14M$13M
EBITDA Margin21%25%24%21%
EBIT Margin10%11%10%10%
Net Profit($871K)$647K($610K)($871K)
Net Margin(1%)1%(1%)(1%)
Net Debt$79M---

Financial data powered by Morningstar, Inc.

Eukedos Stock Performance

Eukedos has current market cap of $17M, and enterprise value of $167M.

Market Cap Evolution


Eukedos' stock price is $0.77.

Eukedos share price decreased by 0.2% in the last 30 days, and by 11.3% in the last year.

Eukedos has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Eukedos
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$167M$17M-0.1%-0.2%31.1%-11.3%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Eukedos Valuation Multiples

Eukedos trades at 2.7x EV/Revenue multiple, and 12.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Eukedos

Eukedos Financial Valuation Multiples

As of June 3, 2026, Eukedos has market cap of $17M and EV of $167M.

Eukedos has a P/E ratio of (20.0x).

Last FY202320242025202620272028
EV/Revenue2.7x2.9x2.8x2.7x
EV/EBITDA12.8x11.6x11.7x12.8x
EV/EBIT26.6x27.6x28.4x26.6x
EV/Gross Profit2.9x3.1x2.9x2.9x
P/E(20.0x)27.0x(28.6x)(20.0x)
EV/FCFn/m40.1x(10.9x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Eukedos Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Eukedos Margins & Growth Rates

In the most recent fiscal year, Eukedos reported gross margin of 95%, EBITDA margin of 21%, and net margin of (1%).

See estimated margins and future growth rates for Eukedos

Eukedos Margins

Last FY20242025202720282029
Gross Margin95%95%95%
EBITDA Margin21%24%21%
EBIT Margin10%10%10%
Net Margin(1%)(1%)(1%)
FCF Margin1%(25%)1%

Eukedos Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth5%2%
Gross Profit Growth5%3%
EBITDA Growth(1%)(8%)
EBIT Growth(3%)7%
Net Profit Growth(194%)43%
FCF Growth(466%)(103%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Eukedos Operational KPIs

Eukedos' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Eukedos
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.1M---
S&M Expenses to Revenue0%0%0%0%
G&A Expenses to Revenue2%1%2%2%
Opex to Revenue85%84%85%85%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
MedNation0.4x-3.8x-
Concord Medical Services7.6x-(48.5x)-
Gesundheitswelt Chiemgau0.5x-4.5x-
Speed Medical SAE----
Maternus-Kliniken1.7x-48.8x-
Clinica de Marly----
Emyria20.8x-(10.7x)-
Amwill Healthcare1.5x-5.0x-

This data is available for Pro users. Sign up to see all Eukedos competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Eukedos

When was Eukedos founded?Eukedos was founded in 2006.
Where is Eukedos headquartered?Eukedos is headquartered in Italy.
How many employees does Eukedos have?As of today, Eukedos has over 1K employees.
Is Eukedos publicly listed?Yes, Eukedos is a public company listed on Borsa Italiana.
What is the stock symbol of Eukedos?Eukedos trades under EUK ticker.
When did Eukedos go public?Eukedos went public in 2006.
Who are competitors of Eukedos?Eukedos main competitors include MedNation, Concord Medical Services, Gesundheitswelt Chiemgau, Speed Medical SAE, Maternus-Kliniken, Clinica de Marly, Emyria, Amwill Healthcare, Latvijas Juras medicinas, Life create.
What is the current market cap of Eukedos?Eukedos' current market cap is $17M.
What is the current revenue of Eukedos?Eukedos' last fiscal year revenue is $62M.
What is the current EV/Revenue multiple of Eukedos?Current revenue multiple of Eukedos is 2.7x.
Is Eukedos profitable?No, Eukedos is not profitable.
How many companies Eukedos has acquired to date?Eukedos hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Eukedos has invested to date?Eukedos hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Eukedos

Lists including Eukedos

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial